The index was also significantly different according to breast cancer subtype (p<0.001, ANOVA test): it was significantly higher in the luminal B, HER2-positive, and triple-negative subtypes than in the luminal A subtype (p<0.001, p=0.004, p<0.001, respectively; Figure 3). This evidence concerns the gene ERBB2 and breast carcinoma.